Mel Sorensen - 20 Nov 2025 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role: President and CEO, Director
Signature: /s/ J. Mel Sorensen
Issuer symbol: GRTX
Transactions as of: 20 Nov 2025
Transactions value $: -$1,407
Form type: 4
Filing time: 24 Nov 2025, 16:42:45 UTC
Previous filing: 05 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sorensen Mel	President and CEO, Director	C/O GALERA THERAPEUTICS, INC., 101 LINDENWOOD DRIVE, SUITE 225, MALVERN	/s/ J. Mel Sorensen	24 Nov 2025	0001444783

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRTX	Common Stock	Sale	-$1.41K	-70K	-26.41%	$0.02	195K	20 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.02 to $0.0201, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.02 to $0.0201, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.